Skip to content

Clinical trials

Lymphoma, T-Cell, Cutaneous trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Phase: Not applicable Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20024
20036
20044
20053
20063
20073
20082
20093
20104
20111
20121
20141
20152
20172
20192
20202
20211
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated14
Withdrawn8
Not yet recruiting3
Recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center9
Roswell Park Cancer Institute5
City of Hope Medical Center4
Assistance Publique - Hôpitaux de Paris3
Case Comprehensive Cancer Center3
Eastern Cooperative Oncology Group2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
OHSU Knight Cancer Institute2
Vanderbilt-Ingram Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous61
Mycosis Fungoides45
Leukemia, Lymphocytic, Chronic, B-Cell43
Lymphoma, Follicular43
Lymphoma, Non-Hodgkin43
Precursor Cell Lymphoblastic Leukemia-Lymphoma43
Sezary Syndrome43
Lymphoma, B-Cell, Marginal Zone42
Burkitt Lymphoma41
Lymphoma, Large B-Cell, Diffuse41

Trials

Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.